Susan A Cotter Selected Research

Eyeglasses (Spectacles)

1/2022	Rasch-calibrated Intermittent Exotropia Symptom Questionnaire for Children.
4/2021	Overminus Lens Therapy for Children 3 to 10 Years of Age With Intermittent Exotropia: A Randomized Clinical Trial.
1/2020	Interventions to slow progression of myopia in children.
1/2012	Optical treatment of strabismic and combined strabismic-anisometropic amblyopia.
12/2011	Interventions to slow progression of myopia in children.
6/2007	Treatment of strabismic amblyopia with refractive correction.
2/2007	Management of childhood hyperopia: a pediatric optometrist's perspective.
6/2006	Treatment of anisometropic amblyopia in children with refractive correction.
6/2006	A randomized trial to evaluate 2 hours of daily patching for strabismic and anisometropic amblyopia in children.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Susan A Cotter Research Topics

Disease

17	Amblyopia (Lazy Eye) 01/2022 - 10/2004
13	Refractive Errors (Refractive Error) 10/2022 - 06/2007
10	Myopia 01/2020 - 03/2003
7	Strabismus (Squint) 10/2022 - 01/2009
7	Hyperopia (Hypermetropia) 01/2019 - 03/2003
6	Anisometropia 01/2019 - 06/2006
5	Ocular Motility Disorders (Convergence Insufficiency) 01/2021 - 10/2012
3	Retinopathy of Prematurity (Retrolental Fibroplasia) 10/2022 - 01/2020
3	Exotropia (Exophoria) 01/2022 - 11/2011
3	Esotropia (Esophoria) 01/2021 - 11/2011
3	Astigmatism 01/2019 - 10/2011
2	Multiple Sclerosis 01/2022 - 12/2020
2	Demyelinating Diseases (Demyelinating Disease) 01/2022 - 12/2020
2	Acute Disseminated Encephalomyelitis (Postinfectious Encephalomyelitis) 01/2022 - 12/2020
2	Neuromyelitis Optica (Devic's Disease) 01/2022 - 12/2020
1	Optic Atrophy 10/2022
1	Pseudophakia 06/2021
1	Diplopia (Double Vision) 01/2021

Drug/Important Bio-Agent (IBA)

15	Mydriatics (Cycloplegics)IBA 01/2021 - 06/2007
8	Atropine FDA LinkGeneric 07/2011 - 10/2004
4	Ophthalmic Solutions (Eye Drops)IBA 01/2020 - 02/2005
4	ORALIT (ORS)IBA 11/2011 - 10/2011
3	Bevacizumab (Avastin)FDA Link 10/2022 - 01/2020
2	Retinaldehyde (Retinal)IBA 10/2022 - 01/2015
2	Myelin-Oligodendrocyte GlycoproteinIBA 01/2022 - 12/2020
2	Biological ProductsIBA 01/2020 - 01/2010
2	Pharmaceutical PreparationsIBA 01/2020 - 12/2011
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022
1	AntibodiesIBA 12/2020
1	Muscarinic AntagonistsIBA 01/2020
1	Timolol (Blocadren)FDA LinkGeneric 01/2020
1	Cholinergic Agents (Cholinergics)IBA 12/2011
1	Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA 12/2011
1	SmokeIBA 10/2011
1	PirenzepineIBA 08/2008
1	altersolanol AIBA 10/2004

Therapy/Procedure

12	Therapeutics 04/2021 - 06/2006
9	Eyeglasses (Spectacles) 01/2022 - 06/2006
5	Aftercare (After-Treatment) 04/2021 - 08/2008
4	Telescopes 01/2022 - 01/2009
4	Meridians (Jing Luo) 10/2012 - 03/2003
3	Contact Lenses 01/2020 - 12/2011
2	Lenses 01/2020 - 12/2011
1	Posterior Capsulotomy 06/2021
1	Hydrophilic Contact Lenses (Hydrophilic Contact Lens) 12/2011
1	Withholding Treatment 10/2004